Aurogra
Designed to support erectile function to manage physical performance and address local vascular blockages.
- Category
- Erectile Dysfunction
- Active ingredient
- Sildenafil
- Route
- Oral use
- Form
- Tablet
- Strengths
- 100mg
Prescription and consultation requirements for Aurogra vary by destination and are determined by the fulfilment partner.
Aurogra details
- Condition
- Erectile Dysfunction
- Alternative names
- sildenafil
- Therapeutic class
- Phosphodiesterase-5 Inhibitor
- Pharmacological class
- PDE5 Inhibitor
- Known off-label uses
- pulmonary hypertension
- Minor side effects
- headache; flushing; indigestion
- Moderate side effects
- nasal congestion; dizziness; visual changes
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Aurochem Laboratories
- Onset Time
- 30–60 minutes
- Duration
- 4–6 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Nitrates; Alpha Blockers; Ritonavir
- Age restrictions
- Approved for adult men.
- Pregnancy and breastfeeding
- TGA Category B: Not indicated for females. Breastfeeding: Not applicable.
Contraindications
concurrent use of organic nitrates; hypersensitivity to sildenafil; severe cardiac disease
Serious side effects
priapism, requires immediate medical attention; sudden vision loss, requires immediate medical attention
Patient summary
designed to support erectile function to manage physical performance and address local vascular blockages.
Mechanism of action
Inhibits phosphodiesterase-5, enhancing nitric oxide activity to expand smooth muscle tissue and increase localised arterial blood flow.